Medicine and Dentistry
Cohort Analysis
98%
Health Care Cost
92%
Methadone
72%
Buprenorphine
72%
Opiate Agonist
63%
Anti-biotics
59%
Electronic Health Record
52%
Intoxication
51%
Cancer Diagnosis
46%
Antiinfective Agent
46%
Population Research
46%
Otorrhea
46%
Secondary Care
46%
Malignant Neoplasm
25%
Diseases
11%
Hazard Ratio
10%
Translational Research
6%
Otitis
6%
Ototoxicity
6%
Amoxicillin
6%
Aminoglycoside
6%
Patient Care
5%
Outpatient Care
5%
Infection
5%
Genitourinary System
5%
Cognition
5%
Cancer Therapy
5%
Gut Microbiota
5%
Proportional Hazards Model
5%
All Cause Mortality
5%
Rodent Study
5%
Cancer Registry
5%
Colorectal Cancer
5%
Leukemia
5%
Immunotherapy
5%
Myeloma
5%
Antibiotic Therapy
5%
Nodular Melanoma
5%
Pharmacology, Toxicology and Pharmaceutical Science
Cohort Study
100%
Buprenorphine
72%
Methadone
72%
Opiate Agonist
69%
Antibiotics
59%
Toxic Injury
53%
Lipophilicity
46%
Malignant Neoplasm
46%
Aldose Reductase Inhibitor
46%
IC50
46%
Antiinfective Agent
46%
Population Study
46%
Otorrhea
46%
Phenol
34%
Antibiotic Agent
23%
Z-Drug
20%
Disease
15%
Diabetic Complication
11%
Aldehyde Reductase
11%
Reduced Nicotinamide Adenine Dinucleotide Phosphate
11%
Infection
7%
Behavior Disorder
7%
Amoxicillin
6%
Otitis
6%
Aminoglycoside
6%
Ototoxicity
6%
